This is to inform you that the company''s Subsidiary, FDC International Ltd., has received Marketing Authorisation from the MHRA, UK, for Atropine 1.0% w/v Eye Drops, Solution.

Date : August 13, 2026 To, National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, Plot no. C/1, Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Dalal Street,Mumbai- 400 001 Bandra (E), Mumbai - 400 051 BSE Script Code: 531599 NSE Symbol: FDC Subject: Intimation under Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) – Grant of Marketing Authorisation from MHRA, UK for Atropine 1.0% w/v Eye Drops, Solution. Dear Sir/Madam, This is to inform you that the Company’s Subsidiary, FDC International Limited has received Marketing Authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom, for Atropine 1.0% w/v Eye Drops, Solution. Kindly take the same on record. Thanking you, Yours truly, For FDC LIMITED Varsharani Katre Company Secretary & Legal Head Membership No. F-8948